Takizawa T, Kojima M, Suzuki S, Osada T, Kitagawa S, Nakahara J
Medicine (Baltimore). 2017; 96(46):e8757.
PMID: 29145329
PMC: 5704874.
DOI: 10.1097/MD.0000000000008757.
Meeusen J, Klein C, Pirko I, Haselkorn K, Kryzer T, Pittock S
Ann Neurol. 2012; 71(3):417-26.
PMID: 22451206
PMC: 3315155.
DOI: 10.1002/ana.22674.
Lacomis D
Neurocrit Care. 2005; 3(3):189-94.
PMID: 16377829
DOI: 10.1385/NCC:3:3:189.
Somnier F
J Neurol Neurosurg Psychiatry. 1993; 56(5):496-504.
PMID: 8505642
PMC: 1015008.
DOI: 10.1136/jnnp.56.5.496.
Vincent A, Newsom Davis J
J Neurol Neurosurg Psychiatry. 1980; 43(7):590-600.
PMID: 7400823
PMC: 490626.
DOI: 10.1136/jnnp.43.7.590.
Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.
JAFFE I
Springer Semin Immunopathol. 1981; 4(2):193-207.
PMID: 7034252
DOI: 10.1007/BF01857095.
Antirheumatic drugs: clinical pharmacology and therapeutic use.
Craig G, BUCHANAN W
Drugs. 1980; 20(6):453-84.
PMID: 7009134
DOI: 10.2165/00003495-198020060-00002.
Historical perspectives on penicillamine.
Fernandes L, Berry H, Hamilton E
J R Coll Physicians Lond. 1980; 14(2):130-6.
PMID: 6965984
PMC: 5373317.
Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
Lipsky P, ZIFF M
J Clin Invest. 1980; 65(5):1069-76.
PMID: 6965944
PMC: 371437.
DOI: 10.1172/JCI109759.
Pathogenesis and treatment of myasthenia gravis.
Scadding G, Havard C
Br Med J (Clin Res Ed). 1981; 283(6298):1008-12.
PMID: 6794741
PMC: 1507269.
DOI: 10.1136/bmj.283.6298.1008.
Remission-inducing drugs in rheumatoid arthritis.
Anastassiades T
Can Med Assoc J. 1980; 122(4):405-15.
PMID: 6768438
PMC: 1801796.
Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.
Behan W, Behan P, Doyle D
Acta Neuropathol. 1982; 57(2-3):221-9.
PMID: 6751015
DOI: 10.1007/BF00685393.
Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
Essigman W
Ann Rheum Dis. 1982; 41(6):617-20.
PMID: 6216862
PMC: 1000997.
DOI: 10.1136/ard.41.6.617.
Diabetes mellitus and myasthenia gravis in a patient with systemic onset juvenile chronic arthritis.
Jenkins E, Hull R, Gray R, Hall M, ANSELL B
J R Soc Med. 1989; 82(6):368-9.
PMID: 2810321
PMC: 1292177.
DOI: 10.1177/014107688908200621.
Ocular myasthenia gravis after D-penicillamine administration.
Katz L, Lesser R, Merikangas J, Silverman J
Br J Ophthalmol. 1989; 73(12):1015-8.
PMID: 2692700
PMC: 1041959.
DOI: 10.1136/bjo.73.12.1015.
Polymyositis complicating D-penicillamine treatment.
Aydintug A, Cervera R, DCruz D, Ramirez G, Asherson R, Khamashta M
Postgrad Med J. 1991; 67(793):1018-20.
PMID: 1775410
PMC: 2399149.
DOI: 10.1136/pgmj.67.793.1018.
Autoantibodies in D-penicillamine treated rheumatoid arthritis.
CAMUS J, Crouzet J, Bach J, HOMBERG J
Agents Actions. 1976; 6(1-3):351-4.
PMID: 1085099
DOI: 10.1007/BF01972254.
Penicillamine in the treatment of rheumatoid arthritis.
Camp A
Proc R Soc Med. 1977; 70(2):67-9.
PMID: 859814
PMC: 1542978.
Pemphigus erythematosus-like rash in a patient on penicillamine.
Scherak O, Kolarz G, Molubar K
Br Med J. 1977; 1(6064):838.
PMID: 851751
PMC: 1606162.
DOI: 10.1136/bmj.1.6064.838-c.
Dermatomyositis complicating penicillamine treatment.
Fernandes L, Swinson D, HAMILTON E
Ann Rheum Dis. 1977; 36(1):94-5.
PMID: 843119
PMC: 1006640.
DOI: 10.1136/ard.36.1.94.